Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck: Strong Pipeline For Dividend Growth
Seeking Alpha
Friday, March 9, 2012 - 4:20pm
tags:
Merck, dividends, GSK, Bristol-Myers Squibb, Pfizer, Sanofi
Novartis' Pipeline Spells Out Strong Growth Potential
Seeking Alpha
Friday, March 9, 2012 - 4:19pm
tags:
Novartis
Big trouble seen for targeted cancer drugs
Fierce Biotech
Friday, March 9, 2012 - 11:27am
tags:
targeted therapeutics, cancer, UK
Speculative Biotech For The Iron-Stomached
Seeking Alpha
Friday, March 9, 2012 - 10:53am
tags:
Geron, Keryx, Dendreon, Advanced Cell Technology, Aeterna Zentaris
A Picture is Worth a Thousand Words: The Difference Between "Yes" and "No" During an FDA Advisory Committee
Elsevier Business
Friday, March 9, 2012 - 10:49am
tags:
FDA, advisory panels, Xgeva, Amgen, Vivus, Qnexa
OncoGenex Doubles Down on Prostate Cancer, As Competition Heats Up
Xconomy
Friday, March 9, 2012 - 10:47am
tags:
prostate cancer, OncoGenex, custirsen
Anaysis - AstraZeneca gets serious on deals as drugs run out
Reuters
Friday, March 9, 2012 - 10:45am
tags:
M&A, AstraZeneca
Boehringer Ingelheim unit Bedford Labs recalling cancer drug cytarabine
Yahoo/AP
Friday, March 9, 2012 - 10:44am
tags:
Bedford Labs, Boehringer Ingelheim, recalls, cancer, cytarabine
DepoMed Beats on Both Top and Bottom Lines
Motley Fool
Friday, March 9, 2012 - 10:40am
tags:
Depomed, earnings
Weight loss drug developer Orexigen posts smaller 4th-quarter loss as costs decrease
Yahoo/AP
Friday, March 9, 2012 - 10:39am
tags:
earnings, Orexigen
Checking an Important Metric at Allergan
Motley Fool
Friday, March 9, 2012 - 10:39am
tags:
Allergan
AstraZeneca citizen petitions on Quetiapine labeling receives FDA response
Yahoo/Fly on the Wall
Friday, March 9, 2012 - 10:31am
tags:
AstraZeneca, FDA, Quetiapine, generics, Seroquel
Merck's hepatitis C drug wins UK cost endorsement
Reuters
Friday, March 9, 2012 - 10:29am
tags:
Merck, UK, hepatitis C, Victrelis
Bellicum snags $20M for mid-stage cancer vaccine program
Fierce Biotech
Thursday, March 8, 2012 - 3:33pm
tags:
BPX-101, prostate cancer, Bellicum
U.S. could bring more common drugs over the counter
Reuters
Thursday, March 8, 2012 - 3:26pm
tags:
OTC, FDA
AIDS Cure Quest Advances as Merck Cancer Drug Attacks Hidden HIV
Bloomberg
Thursday, March 8, 2012 - 3:23pm
tags:
AIDS, Merck, HIV, Zolinza
J&J Prostate Cancer Drug Scores Big Win, Hurts Dendreon, Helps Medivation
TheStreet.com
Thursday, March 8, 2012 - 10:15am
tags:
JNJ, prostate cancer, Dendreon, Provenge, Medivation, Zytiga, MDV3100
Optimer Pharmaceuticals Whiffs on Earnings
Motley Fool
Thursday, March 8, 2012 - 10:14am
tags:
Optimer Pharmaceuticals
Sequenom Meets on Revenues, Misses on EPS
Motley Fool
Thursday, March 8, 2012 - 10:13am
tags:
earnings, Sequenom
The Age Of Personalized Medicine Has Arrived
Seeking Alpha
Thursday, March 8, 2012 - 10:12am
tags:
personalized medicine, Nektar, Life Technologies, Threshold Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.